Synonyms: compound 10 [WO2023283425A1] | PLX4545
Compound class:
Synthetic organic
Comment: PLX-4545 is an orally bioavailable molecular glue degrader of the T cell transcription factor IKZF2 (Helios; IKZF2; Q9UKS7). It promotes selective cereblon-mediated degradation of IKZF2 with the intention of enhancing T cell-mediated anti-tumour immune responses. The chemical structure of PLX-4545 was revealed during the First-Time Disclosures session at the ACS Fall 2024 meeting (Denver, Colorado). This matches compound 10 as claimed in Plexium's patent WO2023283425A1 [1].
|
|
No information available. |
Summary of Clinical Use ![]() |
PLX-4545 has been advanced to clinical evaluation to determine safety, pharmacokinetics and pharmacodynamics in healthy volunteers (see ACTRN12623001265662). |